Advisory board objectives: 1) Gain advice on how Roche can best support Physical Therapists in the management and execution of the SUNFISH and FIREFISH clinical studies 2) Determine the gaps in our understanding of the clinical meaning of change in SMA and define how changes in physical outcome measures can be communicated to diverse stakeholders including regulators, payers, patients/families and prescribers